text:
Formed in 2014 by ACPHS President Greg Dewey, the President's Advisory Council (PAC) is comprised of leaders in the corporate, academic, and not-for-profit sectors.
The Council's overarching directive is to offer insights into how educational institutions should respond to long term trends in the health science and health care industries. The group meets twice per year.
Below is a current list of PAC members and their accompanying bios. To learn more about the Council and its activities, please read the press releases on the sidebar of this page.
Dr. Robert A. Blum has over 28 years successfully operating research programs to effectively research new medications in their early stages of drug development, writing and conducting clinical protocols, and leading a team of medical and supportive personnel in every aspect of running a research-wide program. Dr. Blum co-founded Buffalo Clinical Research Center, LLC (BCRC) in 2001. BCRC is a state-of-art Phase I research facility assisting pharmaceutical companies with early phase drug development. Dr. Blum received his B.S. in Pharmacy from Albany College of Pharmacy in 1983, where he then proceeded to get his Pharm.D. degree from the Medical University of South Carolina in 1985. He completed a Clinical Pharmacy Residency in 1986, followed by a fellowship in Pharmacokinetics in 1987. This experience took him to Buffalo, NY where ascended to the position of Director of Clinical Pharmacology Research at the Clinical Pharmacokinetics Laboratory of Millard Fillmore Hospital. Here he implemented a Phase I research program that grew from 6 beds to 34 beds and was responsible for the procurement, conduct, safety, scientific merit, and regulatory standards of all studies performed. He subsequently worked in Phase I clinical pharmacology research for the next 13 years and then started his own Phase I research company, Buffalo Clinical Research Center, LLC in 2001. The primary research focus of BCRC include "first-time-in-man" safety, tolerability and pharmacokinetic/pharmacodynamic studies, bioavailability/bioequivalence, drug interaction, gender-and food-effect studies. Dr. Blum has acted as Principal Investigator on 250 clinical pharmacology protocols, sub-investigator on 86 protocols, published 63 manuscripts in peer-reviewed scientific journals and presented 45 abstracts at peer-reviewed scientific meetings.
Dr. Bonafede is the Director of the Outcomes Research group of Truven Health Analytics (formerly Thomson Reuters Healthcare). He has significant experience in healthcare research, education, and consulting. Before joining Truven Health, Dr. Bonafede served on the faculty at Albany College of Pharmacy and Health Sciences, where he taught courses covering research and statistical methods, total quality management, and evidence-based medicine. He also helped to design and launch M.S. programs in pharmacy administration and health outcomes research. Dr. Bonafede has conducted and provided training in qualitative research methods and survey design. He also has private consulting experience in survey design, retrospective data analysis, and study presentation. He holds a Ph.D. in health services research and policy and a master's degree in public health, both from the University of Rochester.
Dr. Carpenter is the Senior Director and Head of Clinical Research and Development at Dart Neuroscience (DNS), a San Diego-based pharmaceutical company focused on the development of novel therapeutic agents to improve human cognition and memory. Prior to joining DNS, David held senior leadership roles in the Neuroscience Drug Discovery Group and in the Neuroscience Medicines Development Center at GlaxoSmithKline Pharmaceuticals, and in the CNS Drug Development Group at Sanofi Pharmaceuticals, both in the Philadelphia area. In those roles he was responsible for the clinical development of a variety of investigational neurotherapeutic agents, in both adult as well as pediatric populations, and spanning both early (Phases 1-2) as well as late phase (Phases 3-4) development efforts. During his more than 30 years in the industry, he has been involved in the development of eight drug products to date which have successfully gained regulatory approval for marketing. David is a Registered Pharmacist, and holds a B.Sc. degree in Pharmacy from Albany College of Pharmacy and Health Sciences (class of 1981), an M.Sc. degree in Psychology/Neuroscience from Rensselaer Polytechnic Institute (Troy, NY), and a Doctor of Pharmacy (Pharm.D.) degree from the Philadelphia College of Pharmacy (now University of the Sciences). He is an active member of the College of Psychiatric and Neurologic Pharmacists (CPNP), the American Society of Clinical Pharmacology and Therapeutics (ASCPT), the American Society for Clinical Psychopharmacology (ASCP), the International Society for CNS Clinical Trials and Methodology (ISCTM), and the American Pharmaceutical Association (APhA).
Christopher Conway is Senior Vice President, Discovery and Development, at Albany Molecular Research, Inc. Mr. Conway joined AMRI in 2008 as a Business Development Manager on AMRI's U.S. discovery team. He was promoted to Senior Director of the North America Discovery market in 2010 and then to Vice President of Business Development in 2012 leading an international team of business development managers in North America and Europe. Prior to joining AMRI, Chris held sales and leadership positions of increasing responsibility at Johnson and Johnson and completed J&J's Sales Leadership Development Program. Chris' strong track record in Sales and Marketing stems from the leadership and development of numerous high-profile deals with large pharmaceutical, biotechnology, non-profit, academic, agricultural, and government organizations throughout the world. Chris also led in the development of AMRI's industry-leading insourcing model. This innovative model supports drug discovery, development, and manufacturing for pharmaceutical and biotechnology companies within their own facilities. Chris currently sits on the Siena College Board of Associate Trustees and has been involved with several volunteer boards including the American Cancer Society's Corporate Council and the American Cancer Society's Coaches vs. Cancer initiative. In addition, Chris has worked closely with the national Alzheimer's Association, as well as the Cure Huntington's Disease Initiative and was previously involved as a member of the Albany Epilepsy Foundation Advocacy Board.
As the Vice President, U.S. Medical Affairs at Incyte Corporation, Dr. Cordaro is responsible for leading Medical Affairs Functions including the Medical Science Liaison Team, Publications/Scientific Communications, Health Outcomes Research, and Medical Information Services. He is also responsible for developing and leading the departmental medical strategy and tactical plan implementation. Prior to joining Incyte, Joe was Executive Director, Development Brand Leader at AstraZeneca where he was the leader of U.S. Medical Teams and was accountable for developing brand medical strategy, the medical plan, integration of all pertinent projects into the brand plan, and execution through a cross-functional team. Prior to this, he held the position of Senior Therapeutic Brand Leader, Oncology in Medical Affairs at AstraZeneca, responsible for leading the Oncology Medical Liaison Team, leading the medical affairs core strategy team, and providing brand team support for marketed and late stage pipeline products. Joe previously held positions at Roche Pharmaceuticals most recently as Director Oncology, Scientific Field Operations in Medical Affairs responsible for leading and managing a team of Oncology Medical Liaisons supporting in-line oncology products and pipeline development products. Prior to this he held positions as Associate Director of the Oncology Clinical Liaison Team and Oncology Clinical Liaison. Prior to joining Roche, Joe was at Novartis Pharmaceuticals Corporation as Scientific Officer and Associate Director in the Oncology Business Unit at Novartis Pharmaceuticals Corporation supporting in-line products and development pipeline projects. Prior to this, Joe was an International Project Coordinator for global oncology development products in Global Project Management at Sandoz Pharma, Ltd. Dr. Cordaro received his Bachelor of Science degree in Pharmacy from Albany College of Pharmacy and Health Sciences and his Doctor of Pharmacy degree from the State University of New York at Buffalo School of Pharmacy. He completed a two-year post-doctoral Industrial Clinical Pharmacy Practice Fellowship at Sandoz Pharmaceuticals Corporation and Rutgers University College of Pharmacy where he was Chief Fellow and an Adjunct Faculty member in the Department of Pharmacy Practice. This fellowship focused on oncology and immunology clinical research and development and pharmacoeconomics. Dr. Cordaro received an Executive Pharmaceutical Marketing M.B.A. at St. Joseph's University in Philadelphia, PA. Dr. Cordaro has over 20 years of experience in senior medical affairs leadership, field medical team management, clinical development, scientific communications, medical information systems, as well as a proven track record for enabling impactful and sustainable strategic and tactical plans for Medical Affairs.
Dr. Dadas received his Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences in 2001. During this time in Albany, Dr. Dadas also worked at the Stratton VA Medical Center where he practiced clinical pharmacy and pharmaceutical distribution for four years. After his training at ACPHS, he completed a fellowship in U.S. Clinical Research working in the Critical Care Division of Eli Lilly and Company. As part of his fellowship, he served as Adjunct Assistant Professor at Butler University Pharmacy School, lecturing on research and regulatory topics for a course titled "Clinical Drug Development - A Regulatory View." Dr. Dadas joined Allergan, Inc. in May of 2002 and has held leadership roles as Director of Medical Affairs Operations, Director of Neurosciences Medical Liaisons, Interim Medical Director for Urology, and currently as the National Director for the Urology Medical Liaison Team. Allergan is a multi-specialty pharmaceutical company based in Irvine, CA with a $50 billion market capitalization . Allergan focuses on drug discovery, development, and commercialization in the areas of biologics, devices, small molecules and over the counter products. Dr. Dadas' contributions range across therapeutic areas and products. His work fully integrates medical communications from many internal and external stakeholders, driving corporate research strategy and scientific direction. He has served as a key contributor and leader for Global Medical Affairs strategy and product launches. He has been responsible for design and implementing Phase II through Phase IV clinical research studies. He manages a team of scientists who establish and maintain professional relationships with clinical opinion leaders and clinical research sites. Dr. Dadas serves on numerous sub-teams and corporate councils where decisions are made in the areas of medical communications. He has received two U.S. patents for novel methods of treating diseases where there is a large unmet medical need (U.S. patent # 7,897,147 and 8,685,414) and has additional patents pending.
Tanya Dumrongmanee has a decade of experience bringing operational efficiencies to industries such as e-commerce, higher education, information technology, and manufacturing. She has led cross-functional and global teams at venture-backed startups and highly-matrixed organizations. Her past projects include ERP system implementation, supply chain management process development, and Series C funding. Tanya studied entrepreneurship at Babson College where she earned her Master of Business Administration in 2010. She currently works in product engineering at EMC Corporation and has been with the Fortune 500 company since 2011. She grew up in Los Angeles and now resides in New England.
Mr. Edwards is the Senior Vice President, Mail Service Operations for OptumRx. In this capacity, his primary responsibilities include leading all Mail Service activities, including traditional mail service and all mail fulfillment operations at OptumRx sites, including Specialty Pharmacy fulfillment and the Personal Care program, Pharmacy Practice, and Business Innovation and Operations Support (BIOS) teams. Clayton oversees a team of more than 3,000 employees in five locations across the country that dispenses more than 30 million prescriptions annually.
Clayton has extensive leadership experience in pharmacy and pharmacy benefit management (PBM) settings. He served as senior vice president, Chief Pharmacy Officer with Sanari and as the president of Rhema Healthcare Consulting, specializing in all aspects of PBM management, pharmacy fulfillment and health care marketing. He previously served as the executive vice president, Clinical and Pharmacy Operations for Liberty Medical, a leading direct-to-consumer provider of diabetes testing supplies and prescriptions. In addition, Clayton served in a variety of clinical pharmacy and health management roles with Medco, most notably in the development and management of disease specific programs and the formation of the Medicare Part D business unit, accountable for the State of New Jersey business and the enterprise interactions with the Centers for Medicare & Medicaid Services (CMS). Clayton received a Bachelor of Science degree in pharmacy from Albany College of Pharmacy and Health Sciences and his Master of Business Administration (MBA) in health administration and marketing from Saint Joseph's University. He is a member of the Academy of Managed Care Pharmacy (AMCP) and the American Pharmacists Association (APhA) and holds a professional certificate from the Academy for Healthcare Management (AHM).
Shahrokh (Seve) focuses his law practice on patent and trademark law, with particular emphasis on patent and trademark filings, prosecution, and client counseling. Seve takes into account clients' business goals to provide a full range of counseling, patent and trademark filings and prosecutions, and agreement services to his clients. He has more than nine years of experience managing patent portfolios and represents many U.S. based and foreign based clients with interests in new and emerging technologies. His clients range from university faculty and researchers, to start-up companies developing new technologies, and larger established corporations. Seve is the Managing Partner of Albany-based FALATI Intellectual Property Law & Management Consultancy firm, leading a group of seven experienced Intellectual Property law attorneys. Seve is admitted to practice law in New York and Massachusetts, before the United States District Court for the District of Massachusetts, and as a registered patent attorney before the United States Patent & Trademark Office. Prior to entering the legal profession, Seve graduated with a B.Sc. with Honours and a Ph.D., both in Pharmacology, while studying in the United Kingdom, and completed a three year Postdoctoral Fellowship at Harvard Medical School / Beth Israel Deaconess Medical Center.
Helen is Executive Vice President, Global Strategic Development, LumiraDx, USA, Inc. responsible for building international collaborations and global best healthcare technology solution portfolios.
Before joining LumiraDx, USA, Inc. she was in HIMSS senior leadership (Health Information Management Systems Society) and previously to that excelled in three Fortune 500 companies. She has an extensive healthcare and healthcare technology background, developed nationally recognized client loyalty programs, best practice programs and various governmental healthcare reform initiatives, both nationally and on the international level. She has achieved Health Information and Management System Society (HIMSS) fellow status and secured HIMSS designation of Certified Professional in Health Information Management System (CPHIMS). She serves on committees and Boards for various organizations such as HIMSS, CHIME (College of Healthcare Information Management Executives), The Sullivan Institute for Healthcare Innovation and WEDI, State University of New York's Global Institute for Health and Human Rights, the State University of New York's Center for Global Health. She is currently serving on the committee for the strategic planning initiatives for the University at Albany SUNY Center for Global Strategic Health. She serves as the HIMSS National Liaison for the State of New York. She has secured service awards and various career recognitions and has published and lectured extensively in healthcare and healthcare technology.
She authors a quarterly healthcare technology column educating clinicians about healthcare technology solutions and processes. She holds academic appointments at University of Maryland and the Sage Colleges, New York. She has a Baccalaureate in Science, a Doctorate of Pharmacy, and trained in the Harvard teaching hospitals, Boston, MA. She completed a drug information research fellowship, has an MBA in healthcare administration,is a Certified Six Sigma Black Belt and Certified Six Sigma Lean Sensei. She was named by Health Data Management's as one of "The Most Powerful Women in Healthcare IT Thought Leaders 2016". Helen is passionate about giving back and mentoring others in the healthcare industry. She authors the column in US Pharmacist called "TechRx" educating pharmacists on the nuances of healthcare IT and various technology solutions.
She volunteers her time and skills and supports fundraising efforts for various organizations supporting the environment and humanity.
Tom Garcia is a Research Fellow in Global CMC, Pfizer Inc., Groton, Connecticut. He received a B.S. in Pharmacy from Albany College of Pharmacy in 1983, and a Ph.D. in Industrial and Physical Pharmacy from Purdue University in 1989. Tom has over 26 years of experience in the pharmaceutical industry. He spent the first 14 years doing process development and technology transfer, where his primary interests were powder mixing, blend sampling, and the use of statistical techniques to optimization and assess process capability and robustness. He joined Pfizer's Global Chemistry and Manufacturing Controls (regulatory) group in 2003. He is a member of the GCMC Advisory Office, working with cross-functional teams to define development and regulatory strategies that generate the data required for the preparation and submission of global NDAs/MAAs, as well as responses to regulatory queries and observations. Tom is also a member of Pfizer's License and Management team where he assesses the quality and value of external opportunities. He was a member of the SUPAC IR Industry Training Committee, served as Chair of the PQRI Blend Uniformity Working Group, and was a member of the MIT Regulatory Sub-Team for continuous manufacturing (2014). Tom has been active in ISPE, serving on various Groups (BUCU Group (leader), ISPE Process Capability Statistics Group, Control Strategy Task Team), and is a member of the Rutgers C-SOPS Continuous Manufacturing Regulatory Working Group. He is an Adjunct Associate Professor in the Department of Pharmaceutical Sciences at Albany College of Pharmacy and Health Sciences, and held a similar position at Campbell University from 1996 – 2000.
Marylee Grosso, RPh is managing partner of HealthCare Consulting Service (HCS), an independent consulting company that addresses the challenges faced by post-acute care providers, vendors and professional organizations in a rapidly changing regulatory and reimbursement environment. A healthcare executive, with over 30 years of professional clinical management experience, Marylee most recently was Corporate Senior Director of Clinical Operations for Genesis Healthcare, overseeing the clinical pharmacy practice standards of the Nursing and Medical Affairs Departments in over 510 centers nationally. In this capacity, Marylee was responsible for Clinical Pharmacy Programs with focused attention on the development of a comprehensive medication reconciliation process for patients admitted to Genesis PowerBack Centers. Additionally she was the clinical liaison with the Genesis pharmacy providers and managed the regulatory compliance monitoring and reporting processes for Genesis. Prior to joining Genesis, Marylee was a clinical pharmacist specialist with the VA Medical Center in Syracuse, New York responsible for clinical pharmacy program management. She holds a bachelor of science degree in pharmacy from Albany College of Pharmacy and Health Sciences and is a member of the national and Maryland Chapters of the American Society of Consultant Pharmacists (ASCP) and the American Healthcare Association (AHCA). She has been a guest speaker for ASHP/INS; the District of Columbia and Delaware Healthcare Associations, the American Society of Consultant Pharmacists LTC Marketplace, and the ASCP and AHCA national meetings. She has served on the AMDA Immunization Work Group, the ASCP Pharmacy Quality Alliance's workgroups for MTM (Medication Therapy Management) and Medication Error Management and the Committee for Innovations, MDASCP CRISP Workgroup and the AHCA Regulatory Affairs, Adverse Events and Clinical Practice Committees.
Frank Grosso has 35 years of Long Term Care (LTC) Pharmacy experience and is currently Executive Director and CEO of the American Society of Consultant Pharmacists. Prior to his current position, Frank was Vice President of Pharmacy Services for Genesis Healthcare, a Long Term Care Provider, with corporate headquarters in Kennett Square, PA. His responsibilities included oversight of the operational and contracted pharmacy services for 411 Nursing Centers and Assisted Living Communities owned and managed by Genesis. Frank's experience began with Consultant Pharmacy and includes LTC Pharmacy Sales and Operations Management and serving as Senior Vice President of Pharmacy Operations for NeighborCare Pharmacy for 14 years. In addition to ASCP (1980) and AHCA (2006) memberships, Frank has been an active participant in several AHCA and ASCP Committees including Pharmacy Advisory Group, DEA Taskforce, and Policy and Advocacy.
As vice president of National Pharmacy Programs and Services at Kaiser Permanente, David Kvancz oversees Pharmacy operations across the Program to ensure it is positioned to optimize performance and delivery of quality, service, affordability, and technology. Kvancz collaborates with key leaders and physicians to find new and effective ways to integrate clinical pharmacists into the care delivery and chronic disease management to achieve systemwide improvements in patient care outcomes. A nationally-known leader in clinical pharmacy operations, Kvancz came to Kaiser Permanente from The Cleveland Clinic. He began his career there in 1997 as director of pharmacy and in 2003 was promoted to chief pharmacy officer. In that position, he directed the operation of all pharmaceutical care services throughout the system, including integrating pharmacy services into clinical practices and partnering closely with physicians. Kvancz previously served as the associate director of clinical pharmacy services at the University of Texas Medical Branch at Galveston from 1994-1997, where he directed inpatient and ambulatory pharmaceutical care practices. From 1982-1994, he served as assistant director of pharmacy at Tucson Medical Center's inpatient and ambulatory pharmacy operations and practice models including pharmacy information and automation support services. Kvancz has served as a member and chairman of the American Society of Health-System Pharmacists' (ASHP) Practice Managers Section, as a member and co-chair of the Organizational Affairs and Professional Affairs Councils, and as a member of the ASHP and Georgetown University Center for Health System Pharmacy Leadership Development Advisory Committee. He was named a Fellow of ASHP in 1990. He earned a bachelor's degree in pharmacy from Albany College of Pharmacy and Health Sciences and a master's degree in hospital pharmacy from Ohio State University. He completed his ASHP-accredited residency at Mount Carmel Medical Center in Columbus, Ohio.
As the Executive Director for the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (AMI-USC), Dr. Lasch brings more than 25 years of experience in science and technology development and evaluation in the fields of biomedical instruments and systems, biotechnology, chemistry, and materials science. He is a Research Professor of Biomedical Engineering in the Viterbi School of Engineering and holds a courtesy appointment as a Professor of Clinical Entrepreneurship in the Greif Center of the Marshall School of Business at USC. Prior to joining AMI-USC, he served as a Managing Director of Convergent Ventures (CV), an early stage life sciences venture investment and development company. He has served as chairman or member of the boards of directors and CEO of several CV portfolio companies. From 2002-2007, he was on the board of directors of Precision Dynamics Corporation, a privately held healthcare products company, and he currently serves as vice chairman of the board of directors of the Southern California Biomedical Council. Dr. Lasch has held leadership positions at Materia, a materials science company spun out of Caltech, where he served as founding President and CEO, and Cyrano Sciences, a Caltech spin-out based on chemical sensor technology. Previously, he served as vice president of technology development for The Scripps Research Institute, the largest not-for-profit biomedical research institute in the United States and was director of research, biotechnology, for PPG Industries. He has served on the faculty of the UCLA Anderson School of Management, in the FEMBA GAP program and for two years as the Director of the EMBA Field Study Program. He received his B.S. in Biological Science from the University of Texas at El Paso and his Ph.D. in Chemistry from the University of Texas at Austin. Dr. Lasch is also a Fellow of the American Institute for Medical and Biological Engineering. He is co-author of Seed-Stage Venture Investing: An Insider's Guide to Start-Ups for Scientists, Engineers, and Investors.
John is the Area Healthcare Supervisor for Upstate and Western NY for the Walgreens Co. He is responsible for executing regional healthcare strategies that integrate all Walgreens healthcare offerings. He advises on pharmacy strategy, engages and empowers others, leads change, and drives results using management principles, employee development, and relationship building.
John received his B.S. in pharmacy from Albany College of Pharmacy and Health Sciences in 2003 where he served as president of his class.
In September 2014, Mr. Marraffa was appointed to the New York State Board of Pharmacy. He serves on the National Association of Boards of Pharmacy Task Force on the Regulation of Pharmacist Care Services, where he is responsible for reviewing existing state laws and regulations pertaining to the provision of pharmacist care outside of the traditional pharmacy setting. The task force reviews and recommends revisions to the NABP Model Act to assist other boards of pharmacy.
In April 2014, Governor Cuomo's office appointed Mr. Marraffa to the New York State Medicaid Pharmacy Advisory Committee. On this committee he provides expertise related to developing and maintaining Medicaid policies that improve patient healthcare outcomes while supporting the practice of Community Pharmacy.
John serves as an adjunct experiential preceptor for Albany College of Pharmacy and Health Sciences and Massachusetts College of Pharmacy and Health Sciences University. He is an active member of the ACPHS Professionalism Task Force, Experiential Education Advisory Panel, and was President of the ACPHS Alumni Council from 2008 - 2011.
As an involved community member, John has served on the American Cancer Society's Relay for Life Planning Committee and received the Shining Star Award in 2011 for exemplary service to the organization.
John and his wife Lauren have two sons, Nico and JJ, and a boxer dog Roxy. They reside in Fayetteville, NY.
Stephen is passionate about the development of medical products, technologies, and services that address unmet medical needs. He has had the good fortune to participate as an active executive, investor, and board member to more than two dozen companies in the industry. He has contributed to the development of numerous medical therapies and products across many areas of medicine. His scientific contributions and patents include delivery of drugs to the eye, medical devices for the treatment of tinnitus, allergy vaccines, and diagnostic tests for cervical cancer. For the past several years, the advancement of mental health and substance abuse treatment has been part of these pursuits – in both the healthcare delivery aspects and through development supportive mobile health applications. Dr. McCormack currently serves as Chairman of the Board of Directors and Chief Executive Officer of Visus Technology. Visus is advancing mobile accessibility technology through the development cloud-based computer vision solutions for the elderly and visually impaired communities. Other companies that he co-founded and operated include: AlleCure, MannKind, NeuroSystec, CytoMx, Cynvenio, American Optical Services and Exela Hearing Services. He lived in Europe for four years and was a Managing Director at Global Life Science Ventures in Zug, Switzerland and the Chief Executive Officer of Intelligent Medical Implants in Bonn, Germany. He has previously held academic positions at Georgetown University Medical Center, Rockefeller University, George Mason University, and the UMMC and was part of the founding senior management at the Keck Graduate Institute. Dr. McCormack received his Ph.D. in the Interdepartmental Biomolecular Science and Engineering program from University of California, Santa Barbara. He obtained a bachelor's degree in biology from the College of the Holy Cross in Worcester, MA.
As the Vice President of U.S. Metabolic Marketing, David leads the marketing organization for the BI-Lilly Diabetes Alliance. This portfolio includes two products currently on the market and six more in Phase III. David concurrently managed the Pradaxa and mature brands business for almost a year prior to the role being split in two which allowed him to focus completely on the Diabetes Alliance. Prior to his current role, David spent 2 1/2 years with responsibility for all U.S. Pipeline Marketing activities from Discovery to Phase III across all therapeutic areas at Boehringer Ingelheim. Prior to joining Boehringer, David spent five years at J&J with four of them having a board position at Ortho McNeil, a J&J company. While at J&J he was responsible for their Pain Franchise which included Duragesic, Ultracet, and Ultram ER and then the Institutional Franchise which included the launch preparation for two new antibiotics as well as the existing pain and anti-infective business. Prior to J&J, David spent 10 years at Bristol Myers Squibb starting out in field based medicine progressing through strategic and in-line marketing with therapeutic experience in diabetes, schizophrenia, hyperlipidemia, hypertension, depression, and dermatology. David spent two years in the U.K. running the Primary care marketing business for BMS. David received his B.S. and Doctor of Pharmacy degree from Philadelphia College of Pharmacy and Sciences (now University of the Sciences).
Dr. Pickworth is a pharmacologist with more than 30 years of preclinical and clinical experience. He received a B.S. (pharmacy) degree from Albany College of Pharmacy and Health Sciences (1969) and a Ph.D. (pharmacology) from the University of Tennessee (1974). He was with NIH for nearly 30 years from a post-doc position to a tenured staff scientist at the National Institute on Drug Abuse. For the past ten years he has directed clinical research on tobacco and nicotine for Battelle as a Research Leader. He has served as a principal investigator throughout his career. He has published more than 100 peer review papers, book chapters, and technical reports. Dr. Pickworth has worked with numerous collaborators, including NIH colleagues, academic and health care institutions, private industry, and national and international scientific and regulatory agencies. Wallace is still active in pharmacy, holding licenses in two states, working part-time in hospital pharmacy, and serving as an adjunct faculty at two colleges of pharmacy. His current research centers around the delivery of toxicants from tobacco products including oral tobacco, cigarettes, cigars, and e-cigarettes.
Dr. Triller is Vice President of Network Transformation at MVP Healthcare in Schenectady, New York. In this capacity he leads MVP efforts in engaging providers and health systems in value-based purchasing agreements that improve patient outcomes by incentivizing high quality, high efficiency services across care settings. Prior to joining MVP in 2015 Dr. Triller was a Senior Project Director for IPRO, the Centers for Medicare and Medicaid Services (CMS)-designated Quality Improvement Organization (QIO) for New York State where he led multiple drug safety and quality improvement initiatives at the local, state, and national levels. He assembled and led the NYS Anticoagulation Coalition, a multidisciplinary group of over 160 clinicians and healthcare professionals collaborating to enhance the quality and safety of anticoagulant (AC) therapy. He also created and led similar Coalitions focusing on hypoglycemia avoidance, appropriate opioid use, and hypertension control.
Dr. Triller has contributed to several national efforts to develop, test, and implement drug-related quality measures and to promote quality improvement across the pharmacy community. He served as a member of the Technical Expert Panel (TEP) for the CMS medication quality measures development and management program led by Florida Medical Quality Assurance, Inc. (FMQAI) and is a member of the Medical and Science Advisory Board for the National Blood Clot Alliance. He also contributes to medication quality measure TEPs for the Pharmacy Quality Alliance (PQA) and the American Society of Health-System Pharmacists (ASHP). He has served as president of the NYS Chapter of the American College of Clinical Pharmacy (ACCP) and is past chair of the NY Pharmacy Conference.
Dr. Triller received both his B.S. and Pharm.D. degrees from Albany College of Pharmacy and Health Sciences (ACPHS). He completed a post-doctoral fellowship in drug safety at ACPHS, and has led numerous funded studies and peer-reviewed publications on the topics of drug safety and quality improvement throughout his 25+ year career in pharmacy. He holds an adjunct clinical faculty appointment at the college, and is an active author, speaker, and advocate for drug safety topics.
Mr. Edward A. Ullmann, brings leadership, experience and skills as an executive manager with a unique background in both private and public sectors of the health care and wellness industries. He has developed more than 30 start-up companies, and for 16 years served as the Founder, Chairman, President, and Chief Executive Officer of a publicly-traded New York-based health management company (Wellcare). Wellcare developed and managed six operating HMOs. Mr. Ullmann is a licensed pharmacist with retail experience as a Pharmacy District Manager (PDM) and operator of independent pharmacies. Mr. Ullmann's international experience includes development of a nationwide prepaid health plan in Mexico (MediPlan), owner and operator of world-renowned Warm Mineral Springs, and CEO of wellness company Bienestar, Inc.. Mr. Ullmann's public sector experience includes serving as a mental health director and county legislator (age of 25). Mr. Ullmann is an outspoken leader and innovator in the health care industry and has received numerous recognitions, distinctions, and awards. In 1994, he was named Health Care Entrepreneur of the Year in Southern New England in the Entrepreneur of the Year national competition sponsored by Inc. Magazine. In 2007, Mr. Ullmann received the CHIP Visionary Award from Sarasota County, Florida. Mr. Ullmann holds a B.S. degree in Pharmacy from Albany College of Pharmacy and Health Sciences, an MPA degree from the Maxwell School of Citizenship and Public Affairs, Syracuse University, and was a National HMO Fellow at Georgetown Medical School, Washington, DC.


text:
If you would like to ship your items to a different country, please select it below. Item availability, prices and shipping will be updated to reflect that country.
Please select the language that you would like to browse the site in.
Please select the currency that you would like to pay with.
Style: 39337845 Colour:
With allover metal stud detailing this maxi gown features a plunging V-neckline and a drawstring waistband. Slit detailing on the long sleeves and ties on the cuff. Lined.
Meadows Maxi styled by the FP Me community
Hey you!
Be the first to write a review.

subset: commoncrawl


text:
My QLA7 -
Someone gave me this, needs attention -
My QLA7 -
Someone gave me this, needs attention -
Location: Yorks
Posts: 16,649
I'm Nobody.
Welcome Roy, Whats the Manticore 45? Is it Greg Lake 'I Believe in Father Christmas' flip side 'Humbug' ?
Yes it is; the 'Humbug' side... I simply read the label, though. I suspect that you arrived at the fact through somewhat cleverer means
Welcome, Roy!
"A man is a success if he gets up in the morning and gets to bed at night, and in between he does what he wants to do". - Milan Kundera.
"Your validity or worth are not defined or determined by the views of others with their own superimposed agendas". - Pharos (on AoS)
My system:
Modified Technics SL-1210MK5G/Mike New high-precision bearing & baseplate/Mike New ETP platter/Bruil record weight/Nagaoka GL602 crystal T/T mat. Paul Hynes SR7EHD PSU (plus regulator modules)/DCSXL pure-silver DC lead. Ortofon RS-212D tonearm/'Speedy Steve' custom-made Ebony armboard. Yannis Tome 423.5 Phono Silver-Litz tonearm cable, with Furutech CF-DIN(R) and Eichmann silver Bullet Plugs. Cartridges: Denon DL-S1 in AT MG-10 headshell with AT-6106 Quattro Hybrid lead-wire. Denon DL-103C1 in '103U' headshell with AT-609 silver lead-wire. Vintage Denon DL-103AU in AT-Ti15ANV Titanium Headshell. Shure M55E in Denon PCL-300 headshell with 6N silver lead-wire. Shure original USA SC35C. Audiocom-modified Sony X-777ES/DAS-R1 transport/DAC. Raspberry Pi-3 Model B and IQaudio Pi-DAC+/Paul Hynes SR3DR-05 linear PSU/Williams Audio NAS linear PSU. Heavily-modified Croft Charisma-X preamp. Stereo Coffee LDR. Head-amp: Paul Hynes design/SR5 PSU. Also modified Lentek. Tube Distinctions 50W Class A P/P Copper amp with cryo-treated Tung Sol KT150s. Speakers: 'Lockwood Majors', using 15" Tannoy Monitor Golds, modified with bespoke crossovers. Also Celestion Ditton 15XRs. Stands: Mana Acoustics (non-magnetic stainless steel 'clones). Hi-Fi Racks Podium T/T wall shelf. Sony ST-5055L tuner. Cables: Furukawa EE/F-S 2mm & 2.6mm solid-core mains leads, fitted with Furutech FI-50 IECs and FI-1363Rs. Stereo interconnects: Sommer Carbokab 225 (with silver-plated MS Audio non-metallic POM RCAs). Speaker cable: VDH 'The Wind' Hybrid II. Digital coaxial cable: 1m Trompeter Electronics Triax TRC-75-2, with MS Audio Starline' silver-plated RCAs. Mains block: Mark Grant 6-way, modded with Furutech FP-1363R sockets and Furukawa cable. Tube Distinctions digital noise filter. VPI HW 16.5 record cleaner.
Location: Yorks
Posts: 16,649
I'm Nobody.
I saw the Greg lake but know that was the only single he had on Manticore
Yes, it's the B side of Greg Lake's Xmas single. I was using this to try the turntable out as I'm not sure on the condition of the cartridge. Turns out it's probably only worthy of the skip which is a shame as it's a proper old thing.
Last edited by Roy S; 15-11-2011 at 18:27.
Just picked up these two beauties (e-bay bargain), they both seem to work very well. What cartridges work well with the standard arm?
Bedroom turntable, sounds brilliant but I keep pulling the belt off when I take a record off and if I breathe on it hard the little anti-skating weight drops off.
hello Roy
Love the boxer avatar,
great collection there, love the turntables. last one looks interesting
Amps: Technics SU-V9, SU-V8 (black and silver), V8X, V4X and G50
Source:Technics SL-P990 , P990, P350, P477a,PG440a, Marantz CD50, Klein DAC, tuner and turntables Technics
Speakers: Technics SB-6, Coral CX-5, ESM bookself (seas tweeters), Celestion Sl-6 (copper domes)
Location: Northamptonshire, UK
Posts: 8,389
I'm Dave.
If it were me Roy I'd lose the Project and replace it with one of the 1200's, you won't regret it. I'll leave the cartridge recommendation to those better equipped to advise you
[COLOR="#2F4F4F"][SIZE="1"][B]Sources:[/B] Win7 music server ~ Meridian 206 CDP ~ Sony ST73 Tuner ~ Sony MDS-JE480
[B]Amplification:[/B] Trio KA-801
[B]Speakers:[/B] Monitor Audio R852's
[B]Ancillaries:[/B] Rega DAC ~ Superlux 668B Headphones[/SIZE][/COLOR]
[FONT="Palatino Linotype"][B][COLOR="DarkRed"]AoS: [/COLOR][COLOR="Grey"]The [COLOR="DarkRed"]HEART[/COLOR] of sound...[/COLOR][/B][/FONT]
A learning experience is one of those things that says, 'You know that thing you just did? Don't do that.
exactly what I was going to do Dave (& I've put a Lenco arm on my list to Santa)


text:
La Incidencia de las Políticas Públicas sobre la Actividad Rural, el Escenario Comparado y la Propuesta de Reforma Tributaria
The paper analyzes public policies on the rural sector implemented in our country, within an international compared approach, and its implications for Argentina's economic performance, particularly its agricultural sector. The analysis derives toward our insistence on the need for a federal tax system reform, particularly referred to real state and land taxation, and the role that within this tax source has the Rural Property Tax (Impuesto Inmobiliario Rural) in provinces. A new explanation of the characteristics of this tax reform is advanced in the paper.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
|102 pages
|Date of creation:
|Mar 2013
|Contact details of provider:
| Postal: Calle 48 No555 - La Plata (1900)
Phone: 21- 1466
Fax: 54-21-25-9536
Web page: http://www.depeco.econo.unlp.edu.ar/doctrab.php
More information through EDIRC
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Paolo Liberati, 2001. "The Distributional Effects of Indirect Tax Changes in Italy," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 8(1), pages 27-51, January.
This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.
When requesting a correction, please mention this item's handle: RePEc:lap:wpaper:096. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Diego Fernandez Felices)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.


text:
Cherie – Sophie Srej (IMG Paris) models refined accessories in the latest story lensed by Michelle Du Xuan for Harper's Bazaar China October. Stylist Hanae Uwajima mixes elegant millinery with jewelry that gives Sophie a vintage flavored beauty, emphasized by dramatic waves and curls by Shuko Sumida. / Make-up by Min. K, Assistant: J.M Chassier
Pauline Van Der Cruysse & Zhu Lin Star in a Couture Fairytale for L'Officiel China by Michelle du Xuan
Haute Fairytales – Photographer Michelle Du Xuan brings us this stunning editorial from the September issue of L'Officiel China, featuring models Pauline Van Der Cruysse (Elite Paris) and Zhu Lin (IMG Paris) in a kaleidoscopic time traveling fairytale. Styled by Hanae Uwajima, the girls don a marvelous wardrobe of couture pieces by Elie Saab, Dior,… [Read More]


text:
Jim and Linda (ne Snyder) Mosher of Lakeville celebrated their 40th wedding anniversary Feb. 19, 2017.
The couple were married Feb. 19, 1977, by Pastor Robert Pflueger at Zion Lutheran Church in Loudonville.
Current subscribers have full access to all online news content as part of their subscription. If you are a current subscriber, please log in with your website account information for full access. If you are a current subscriber, but have not yet registered for access to the website, please call our Circulation Department at (419)281-0581


text:
On This Date: December 5
Monday, December 5, 2016
Klay Thompson of the Golden State Warriors scored 60 points in a 142-106 win over the Indiana Pacers.
Wednesday, December 5, 2007
Allen Iverson of the Denver Nuggets scored 51 points in a 111-107 loss to the Los Angeles Lakers.
Tuesday, December 5, 2006
Steve Nash of the Phoenix Suns dished out 20 assists in a 127-102 win over the Sacramento Kings.
Thursday, December 5, 1996
6-time All-Star Jermaine O'Neal made his NBA debut for the Portland Trail Blazers in a 115-104 win over the Denver Nuggets.
Wednesday, December 5, 1962
Tom Gola was traded from the San Francisco Warriors to the New York Knicks.


text: tbdress.com give you the newest cool merchandises around the finest at wholesale prices monetary value, we certain our items appreciate high quality.should you baffled any time dealing with assorted ball gown tiered gownsin industry, we are going to enable you to resolve your queries. you'll get very comprehensive ware facts from your web page and create a rational decision.whatever you are searhing for any style ball gown tiered gownsor maybe a long lasting 1, massive share within tbdress.com is not going to enable you to disappoints. precisely what'utes to a greater extent, the retail price you observe is incredibly awe-inspiring affair.you can not pass up ball gown tiered gownsin this web page where you can find the newest vogue design and style. living in this particular globe, all of you can purchase anything in your web site mainly because we've got your world-wide insured marketing network.tbdress is the greatest dealer in the world who can give you the ideal ware, remarkable cost along with patient products and services.


text:
Getting ready for the holidays can be a lot of fun, but it can also be a stressful time. No one wants to spend the holidays in a rush, so why not slow down and take time to enjoy the holiday season? If you have waited to start your holiday shopping, you are not alone. Millions of consumers will be shopping for holiday gifts over the next few weeks, but you don't have to get caught up in the last minute gift buying frenzy. Plan to make a few smart purchases over the next couple of weeks, and you'll be ready to celebrate the season with your loved ones.
To save time and money, make some homemade gifts for friends and family. If you have a lot of people that you want to show your appreciation for during the holidays, homemade gifts can go a long way. Homemade sugar scrubs and spa products, such as bath bombs are great gift ideas for anyone who loves to unwind and relax. You can easily make your own soaps or candles, using simple ingredients or kits that you can purchase online, or at a craft store. You could even make homemade bake good or chocolate candies. You can find candy making supplies at Joann, and get free shipping off of your purchase of $6.0.00 or more. Don't forget to plan to give some of these lovely gifts to your mail carrier, teachers, pastors, and anyone else you might want to say a special 'thanks' to during the holidays.
To save even more time and money, shop online. More and more consumers are doing the bulk of their holiday shopping online. It's much more convenient than going out in the cold, battling the traffic, and long lines at the store. When you shop online, you can search for exactly the product you're looking for, without having to hope that a retail store will have what you're looking for. You can still have customer service available to you, and there will be no crowds to deal with, unless there's a crowd on your couch. You can shop leisurely through out the day, make purchases in the middle of the night when you're startled awake by a great gift idea, and never have to change out of you pajamas or yoga pants.
Do a one-stop-shop. Choose one store that you can purchase gifts for everyone on your list from. Old Navy is a great option. Not only do they have apparel for the entire family, they also have cool accessories and jewelry. They offer E.L.F. Cosmetics, so you have the option to purchase makeup for stocking stuffers. There are also lots of great bins near the check-out for stocking stuffer options. You can even shop online, and make it easier on yourself. If you subscribe to Old Navy's e-mail, you can save 30% off your purchase. You can also get free shipping with a $25.00 purchase!
Knowing where the good deals are is half the battle. Do your research, and then plan to shop as much as you can from home. With most sites offering deals on free shipping, you'll save a lot of money.


text:
New Delhi, July 26: The first chargesheet Uttar Pradesh police filed in the Lalitpur trial court in Rae Bareli against L.K. Advani and seven others in the Babri demolition case did not contain the charge of criminal conspiracy under Section 120 B of the Indian Penal Code.
Union law minister Arun Jaitley had based his argument in Parliament last week on this. He had said there was no question of the CBI dropping any charge against Advani, Murli Manohar Joshi, Uma Bharti and others in the case.
According to Jaitleys defence sent to the Lok Sabha Speaker, even FIR no.198 filed against Advani and others did not have the charge of criminal conspiracy under Section 120 B of the IPC.
Jaitley said there were two FIRs filed on December 6, 1992, the day the mosque was demolished. As FIR no. 197 did not pertain to Advani and other leaders, a second FIR no. 198 was filed to include their names. It did not contain the charge of criminal conspiracy under Section 120 B.
On December 13, 1992, FIR no. 197 was referred to the CBI. As FIR no. 198 was not referred to the CBI, investigations were carried out by Uttar Pradesh police and a chargesheet filed at the Lalitpur trial court on February 27, 1993. Even in this chargesheet there was no criminal conspiracy charge against Advani and the others under Section 120 B.
In short, in FIR no. 197 and 198 the chargesheets were different, the accused were different, the investigating agencies were different and the courts where the chargesheets were filed were also different.
According to Jaitleys reply in Parliament, curiously FIR no. 198 was handed over to the CBI which was unprecedented in criminal law history as the local police, after investigation, had already filed the chargesheet on the same FIR.
But the CBI then chose to go ahead with this FIR also and sought to merge the chargesheets relating to both FIRs no. 197 and 198. But to do this, a notification from the government under Section 11 of the Criminal Procedure Code and the permission of the high court was required.
The then Uttar Pradesh governor, Moti Lal Vora, declined to issue such a notification. The state was then under Presidents rule, so the governor had to take a decision in the matter. The high courts permission was also not taken.
Allahabad High Court had quashed this merged chargesheet on the ground that there was no notification under Section 11 of the CrPC constituting a special court to try the case. The high court had then asked the CBI to rectify this error (of non-issuance of notification).
According to Jaitley, the governors adviser on September 9, 1993, gave a detailed opinion that it was prima facie difficult to agree that once a chargesheet has been filed against an accused before a particular judge, the same could be allowed to be filed before another special judge.
The illegal attempt to introduce Section 120 B (for criminal conspiracy) against Shri Advani is foiled by the refusal of the governors adviser to agree to a notification under Section 11 of CrPC, according to Jaitleys reply sent to the Speaker.
The effort to introduce Section 120-B having failed, a unique procedure unknown to law is now adopted without the consent of the governor and obviously without the permission of the high court. An illegal notification under Section 11 is issued transferring Advanis case and allowing it to be subsumed by the Lucknow charge sheet, Jaitley said in his reply to the Speaker.
In this manner, the lesser charges of FIR no. 198 were merged with the larger charges of FIR no. 197 without following proper and legally laid down procedure. So, what do the facts reveal' Jaitley asked. First, the FIR against Advani did not charge him under Section 120 B. Second, the first chargesheet against Advani (filed by the Uttar Pradesh police) did not charge him under Section 120 B. Third, an effort was made to subsume this chargesheet into a larger chargesheet at Lucknow where he could be charged under Section 120 B.
For this, the high courts consent was not taken and the governor had refused to issue the notification under Section 11 of the CrPC. Hence, the high court had set aside the chargesheet. After a Supreme Court order, a notification was issued and the case began again at Rae Bareli.
According to Jaitley, this did not amount to dropping of any charge as the original chargesheet had contained no charge of criminal conspiracy against Advani and the one foisted by illegally merging two different FIRs was quashed by the high court.
He said the desire to introduce Section 120 B surreptitiously and illegally was actually foiled in the case.


text:
- Latest
- Popular
- Blogs
- Authors
- Topics
- Our Blog
… Long Is Long Enough? "Agencies sometimes like to think in short numbers," says Gabe Garner, the SVP of digital development at Firstborn, a New York City-based agency. "Though, if it's on a three- to four-month cycle, that might be a sign of budgetary issues with the brand. But, even if you don't have the budget, a brand should have a longer [content…


text:
Banned Book Tote
Banned Book Mug
Hey, Boo: Harper Lee and To Kill A Mockingbird DVD
20% Off Drama, Mystery & Arts
Composition Notebook Pouch
Banned Books Pouch
List Price: $11.99
Our Price: $8.99
Free Shipping on orders of $59 or more Details >
Item No.: BNBP501
Everyday pouches for literally anything. Canvas pouches with cover art from your favorite classics and fun literary interpretations.More >
AVAILABILITY: In Stock, leaves warehouse in 1 - 2 full bus. days Details >
Reviewed by 1 customer
Comments about PBS Banned Books Pouch:
When I was placing the order, I did not see any dimensions. I looked because I wanted something big enough for notebooks. This pouch is not big enough for books, but I like it. I will find another use. It is hard to believe that these familiar titles have at one time or another been banned.
- Was this a gift?:
- No


text:
On Reflection: FROM HERE TO ETERNITY
As the West End had a bit of a clear-out last night, with Stephen Ward, The Full Monty and The Duck House also making an exit, perhaps From Here To Eternity's departure might be a little overlooked.
It's no secret that I largely enjoyed the show when I reviewed it on press night; I thought the changes made in the following six weeks tightened it up considerably and focused the narrative. I saw it again on a February matinee because I wanted to catch the ever-reliable Stephen Webb as Sergeant Warden; and I concluded my quartet of trips last night for the final West End performance.
Even now, six months after its official opening, there were still notable tweaks in dialogue and score (and some melodrama continues to permeate the script, which I could certainly do without), indicating that perhaps a try-out period in front of an audience might have served the material well.
Indeed, Darius Campbell, in his longest spell in a lead West End role, impressed me on the final night; although he has always sung the role well, he's understandably taken some time to get to grips with characterising Warden in his own way, rather than imitating others or reprising his own previous performances and transplanting them to a different setting.
The love story between Private Robert E Lee Prewitt and the 'princess' prostitute Lorene remains the heart of the show. The outstanding Siubhan Harrison sheds real tears every performance and they were doubled last night as she bade farewell to the show, and she and Robert Lonsdale were clearly heartbroken to be leaving it behind.
I've interviewed Lonsdale twice since the beginning of the run; a thoughtful and articulate interlocuter, he's clearly had a great emotional engagement with Prewitt, and was honest about his own nerves and challenges taking on an immense first singing role. He moves across to television now for his next job, but it would be good to see him return to the West End - and in a musical - again in the future.
Sir Tim Rice gave a speech at the curtain call; in his own inimitable style he apologised to the investors who had lost money, but pointed out that he too was out-of-pocket. He paid tribute to first-time West End composer Stuart Brayson, who seems adamant that the show will go on, albeit outside Theatreland - and we got the first hints of that this week with the mentions of a film release and possible move to Broadway.
The company as a whole, impressive from the outset, can be proud of their work; and from the creatives, Javier De Frutos's wonderful choreography will stay with me for some time. It's not your usual glossy West End musical (although it would be nice to see a sizeable female ensemble in a new show that doesn't cast them as whores). Now, it's a show that gives us everyday heroes and villains, not idealised or demonised, but just as conflicted and complicated as any of us. And it's done with some great tunes along the way.
Related Articles
From This Author Carrie Dunn


text:
Toggle Navigation
I'm an employer
Find a Job
Explore Companies
Career Center
About Us
Log In
Sign up
Administrative Support/Customer Service
Bennington , Vermont
November 12, 2016
Adecco is assisting a local client in recruiting for a current Administrative Support/Customer Service Representative job in Bennington, VT. As an Administrative Support/Customer Service Representative you will perform routine clerical and administrative functions such as drafting correspondence, scheduling appointments, organizing and maintaining paper and electronic files, or providing information to callers. If you meet the qualifications listed below please Apply Now!
Responsibilities for this Administrative Support/Customer Service Representative job include:
• Operate office equipment such as fax machines, copiers, and phone systems, and use computers for spreadsheet, word processing, database management, and other applications
• Set up and maintain paper and electronic filing systems for records, correspondence, and other material
• Answer office telephone and give information to callers, take messages, or transfer calls to appropriate individuals
• Constant contact with customers
• Locate and attach appropriate files to incoming correspondence requiring replies
• Greet office visitors and handle their inquiries or direct them to the appropriate person based on their needs
• Open, read, route, and distribute incoming mail or other materials and answer routine letters
• High School education or equivalent
• Excellent customer service skills
• 1-3 years proven office experience
• MS Office
• Adobe, Windows Media helpful
Pay for this position is $13.00/hr plus overtime as needed. This is a long-term temporary opportunity.
Adecco provides one of the most comprehensive benefits package in the industry to contract workers. Benefits are available to you as a contractor after one week of employment.
Click on Apply Now to be considered for this Administrative Support/Customer Service Representative Bennington, VT or any related opportunities with Adecco.
Equal Opportunity Employer Minorities/Women/Veterans/Disabled
A little about us:
We partner with people to improve skills, teams and lives every day, and we help them achieve more than they ever thought possible.
Share this job
Know someone who would be interested in this job? Share it with your network.


text:
Store's Best Items
|BeOi Trading
|Seller's Address
Basic Information of Product
|Product Status/Sales Type
|Product No.
|Weight (kg)
|1 kg
|Country of Origin
|Shipping Method
Courier Service
|GST Applicable
|Tax Invoice
|Yes (available in My Page)
|After Sale Service
11street receives report on products to protect buyers' right. For further information on safe trade, please contact us.Reportgo
For order related and other issues, kindly click on E-mail Enquiry here.E-mail Enquiry
|8 Inch On-Camera HD DSLR Monitor with 800x480 resolution, a contrast ratio of 500:1 and wide viewing angle makes it perfect for indie filmmakers or freelancers. This 800x480 resolution on-camera monitor for DSLR cameras and camcorders provides a clear and accurate image of what's being recorded without having to look through your camera's tiny built-in monitor. This makes framing, focusing and previewing faster and easier than before while allowing you to position the monitor at different angles without being forced to keep your eye level with the back of the camera. The display on this 8 Inch monitor remains perfectly viewable 140 degrees horizontally and 110 degrees vertically (from the center point). You can be standing adjacent to the monitor and still experience a perfectly clear picture. This feature is useful for when there are multiple cameramen and a director standing around the monitor to view content. This HD DSLR monitor connects to your camera's hot shoe adapter, provides HDMI and VGA inputs and comes with a 6000mAh battery for run-and-gun shooting of up 10 hours. This HD monitor has an enhanced 450 cd/m2 backlight. This produces a crystal clear picture and shows colors vividly, even when used under sun light. Additionally, a light-hood is also provided to ensure a perfect picture under excessive lighting conditions as well as image adjustments like color temperature, red, green, blue adjustments, image flip and more. Professional camera crews and photographers require accurate color representation on their field monitor, and this high resolution monitor provides just the same. The LED matte display has a 500:1 color contrast ratio so colors are rich and vibrant, and the matte display prevents any unnecessary glare or reflection. This in-camera monitor for DSLR is exactly what is needed to view what you are recording.
Seller Information
|BeOi Trading
|Ship-From Address
|Batu Caves, Selangor
|Return/Exchange Address
|Batu Caves, Selangor
|Notice on Return/Exchange
|Our return policy allows for item(s) return and your choice of a full refund or replacement item(s).
Return / Exchange Policy
- Request for cancellation if product has not been dispatched after payment completion.
- Request for return within 7 calendar days following delivery date.
- Check seller's approval on buyer's request.
- Buyer sends product in question to seller.
- Seller receives and checks returned product
- Seller approves return and return is completed.
- Request for exchange within 7 calendar days following receipt of delivery.
- Check seller's approval on buyer's request.
- Buyer sends product in question to seller.
- Seller receives and checks returned product
- Seller send new product to buyer, and buyer receives it, and exchange is completed.
How to Request for Cancellation/Return/Exchange
You can request for cancellation after completing payment and if product has not been dispatched by then, cancellation request is approved and you can receive refund.
But, in case seller has already dispatched product, cancellation request can be rejected.
You can request for return after obtaining product, you should send the product in question to seller.
After seller checks if returned product is flawed, and approves your request, return is completed and payment is refunded.
You can request for exchange if wrong product is shipped, you should send the product in question to seller.
After seller checks if returned product is flawed, seller approves your request, and re-sends new product.
- You can request for cancellation after completing payment and if product has not been dispatched by then, cancellation request is approved and you can receive refund.
Criteria for Return/Exchange
You can request for return/exchange within 7 calendar days following delivery date. But return/exchange request cannot be made in following cases:
- When request due to change of mind is made after 7 calendar days following delivery date
- When product is used, destroyed or damaged
- When tag attached to product is removed or package of product is opened and product value is damaged
- When sealed package is opened or packaging materials are lost
- When too much time has passed and product value has so decreased that its re-sale is not possible
- When return/exchange request is made for customized product such as hand-made shoes or accessories
- When components of product (including free gift) have been used or lost
- When buyer did not follow instructions included in product
- As e-voucher products are immediately sent to your e-mail, returns/exchanges are not available. Please take note of this before purchase, and input your e-mail address correctly.
- As Mobile Top-up products are directly reloaded on your cell phone number, returns/exchanges are not available. Please take note of this before purchase, and enter your cell phone number correctly.
For any inconvenience regarding Cancellation/Return/Exchange, please contact Customer Service at 03-2720 0000 and we will do our best to help you.
- Please note that, direct transaction with the seller without using 11street payment service can cause problems such as; not receiving the product, receiving different product etc.
- For sales products and contents registered by the seller, 11street run by Celcom Planet has no responsibility on any of the registered contents.


text:
Discussion in 'News Zone' started by junk, Jan 23, 2006.
He is still working on it as we speak.
BTW, according to Payton...
say what you want but Zimmer has the players to have a much better defense that we had this year...not that it was bad. We were actually very good, didn't give up a lot of point save the skins game.
However, we gave up 2:00 minute drives almost everytime when the other team needed them and we couldn't get a blitzer to the QB when we went all out blitzes. Ware should've had 12 sacks. And there were a good number of games where pathetic running teams had field days against us...
Raiders, Philthy, etc.
I don't think our defense was bad, I actually think it was pretty good. But I think (and I think I speak for a lot of the GROZ folks here) that we had the personnel to create more sacks and turnovers and wreck more havoc on the opposition than we did. I think its frustrating to many of us that our defense doesn't attack more. Its frustrating to have one of the league's top run stopping, big hitting SS constantly back in coverage. It's frustrating to stuff a team for 58 minutes, only to give up a last minute drive to lose. Its frustrating to see the talent of Ware and Ellis not have double digit sacks or our DBs not have more INTs. I think those are the majority of our griefs with Zimmer.
I see what you are saying, but the thing that blows my mind is that no one holds Parcells accountable for this at all. There is this perception that if Zimmer leaves, Parcells is suddenly going to unfurl this ultra aggressive, blitzing defense.
I just don't see it. I think BP taught Zim this defense, helped him design blitz packages and helped him with play calling. Why the heck else would you dictate that a coordinator change schemes unless you made sure it was run the way you wanted? Doesn't even make any sense.
I don't think Parcells went 3-4 because he thinks it looks prettier on the field.
Of course, if there ever was an aggressive defense in Dallas, we'd hear tons of whining and complaining when it would get beat for a big play.


text:
Let us know when your receive great advice so we can thank our lawyers and point others with similar questions in the right direction.Got it!
mother in law has a revokable trust, she has alzhiemers, she will be in a long term care facility. will they be able to get payment out of the Trust?
Generally speaking, assets in a revocable trust, particularly if your m-i-l established the trust and she is the primary beneficiary, would be attributable to her for purposes of establishing eligibility for Medicaid long-term care coverage. With that being said, you need to review the terms of the trust to see who established it, how your m-i-l is entitled to receive benefits, etc., before a definitive answer can be made. I suggest you bring the document(s) to an elder law attorney in your area for a review. If there is a way to protect the assets in the trust, the attorney will be able to help you do so.
Please note: The above is for general information purposes only. It is not intended to establish and does not establish any attorney-client relationship.Ask a similar question
in most revocable trust situations the money is treated as if it is owned by the grantor (your MIL) so it makes no difference for creditors. An IRRevocable trust is different and the trust document would have to be reviewed to know for sure.
This is not legal advice nor intended to create an attorney-client relationship. The information provided here is informational in nature only. This attorney may not be licensed in the jurisdiction which you have a question about so the answer could be only general in nature. Visit Steve Zelinger's website: http://www.stevenzelinger.com/Ask a similar question
Yes, if this is a trust your mother established and it is revocable, the assets in the trust will be counted as available to be spent on nursing home care before she qualifies for assistance from the state to pay for care. You should meet with a qualified elder law attorney to find out what measures might be able to protect some of her assets.Ask a similar question
I agree with my colleagues. I would simply clarify: the nursing home does not "come after" anything. They are entitled to payment for taking care of your mother. If your mother does not pay, she cannot remain there. The nursing home is not required to house and care for your mother for free.
If your mother has no assets, then the Federal and State governments have welfare programs designed to care for indigents like her. These programs are paid for by taxpayers as a safety net for the poor. If your mother qualifies, then her care would be covered. If she has other assets, then she would not yet qualify for welfare.
Your mother's trust is a resource that she can use to pay for her care. If the trustee refuses to pay for your mother's care, then the nursing home is not required to permit her to stay.
James Frederick
***Please be sure to mark if you find the answer "helpful" or a "best" answer. Thank you! I hope this helps. ***************************************** LEGAL DISCLAIMER I am licensed to practice law in the State of Michigan and have offices in Wayne and Ingham Counties. My practice is focused in the areas of estate planning and probate administration. I am ethically required to state that the above answer does not create an attorney/client relationship. These responses should be considered general legal education and are intended to provide general information about the question asked. Frequently, the question does not include important facts that, if known, could significantly change the answer. Information provided on this site should not be used as a substitute for competent legal advice from a licensed attorney that practices in your state. The law changes frequently and varies from state to state. If I refer to your state's laws, you should not rely on what I say; I just did a quick Internet search and found something that looked relevant that I hoped you would find helpful. You should verify and confirm any information provided with an attorney licensed in your state. I hope you our answer helpful!Ask a similar question
Hello. For a legal issue such as this, you need to have the legal work reviewed by an attorney. Your aim is legally to shelter monies.Some attorneys, myself included, are available seven days for emergency legal needs. Some attorneys, myself included, will confer for free, at no charge: Then, if legal work is performed, some attorneys, myself included, will provide a reduced fee for need. All the best.
Tricia Dwyer, Esq., Elder Law, Estate Planning Law, Rule 14 Qualified Neutral, Minnesota Supreme Court Roster Mediator, Tricia Dwyer, Esq. & Associates PLLC, Phone: 612.296-9666 EVERY DAY OF THE YEAR until 8 p.m. daily. See www.dwyerlawfirm.netAsk a similar question
Post a free question on our public forum.Ask a Question
- or -
Search for lawyers by reviews and ratings.Find a Lawyer


text:
A selection of miscellaneous FDA comments taken from 483's and FDA warning letters. Some are so basic, it is alarming that there are persons in the industry so poorly informed. Others are pure complacency, with a drop of arrogance mixed in.
Details from a FDA warning letters dated 10th November 2009
1) You have failed to establish and maintain procedures to control the design of the device in order to ensure that specified design requirements are met, as required by 21 CFR 820.30(a).
2) You have failed to establish and maintain procedures for the identification, documentation, validation or where appropriate verification, review, and approval of design changes before their implementation, as required by 21 CFR 820.30(i).
3) You have failed to adequately establish and maintain the procedures for receiving, reviewing, and evaluating complaints by a formally designated unit, as required by 21 CFR 820.198(a).
4) You have failed to review, evaluate, and investigate any complaint involving the possible failure of a device to meet any of its specifications, as required by 21 CFR 820.198(c).
5) You have failed to establish and maintain procedures for finished device acceptance to ensure that each production, run, lot or batch of finished devices meets acceptance criteria, as required by 21 CFR 820.80(d).
6) You have failed to validate computer software for its intended use according to an established protocol, when computers or automated data processing systems are used as part of the production or the quality system, as required by 21 CFR 820.70(i).
7) You have failed to document maintenance activities, including the date and individuals performing those activities, as required by 21 CFR 820.70(g)(1).
8) You have failed to establish and maintain adequate procedures to ensure that device history records for each batch, lot, or unit are maintained to demonstrate that the device is manufactured in accordance with the device master record, as required by 21 CFR 820.184.
9) You have failed to maintain a device master record to include device specifications, as required by 21 CFR 820.181(a).
10) You have failed to establish procedures for quality audits and conduct such audits to assure that the quality system is in compliance with the established quality system requirements and to determine the effectiveness of the quality system, as required by 21 CFR 820.22.
11) You have failed to appoint and document such appointment of a member of management who, irrespective of other responsibilities, ensures that quality system requirements are effectively established and effectively maintained and reports on the performance of the quality system to management with executive responsibility, as required by 21 CFR 820.20(b)(3).
12) Your management with executive responsibility failed to review the suitability and effectiveness of the quality system at defined intervals and with sufficient frequency according to established procedures to ensure that the quality system satisfies the requirements of this part and the manufacturer's established quality policy and objectives. The dates and results of quality system reviews shall be documented, as required by 21 CFR 820.20(c).
13) Failure to provide adequate resources
including the assignment of trained personnel, for management, performance of
work, and assessment activities, including internal quality audits, as required
by 21 CFR 820.20(b)(2).
FDA Warning Letters Continued.
Select Preferred Language
When assistance is required; please contact us on TOLL-FREE 877-462-4048
If out of office hours; please leave a voice message.


text:
447 Angel Falls, Springdale, AR 72762
- $682,800
- 1+ Years on site
- Est: $2,530/month
Estimate Your Monthly Payment
Data provided by Informa Research Services. Payments do not include amounts for taxes and insurance premiums. The actual payment obligation will be greater if taxes and insurance are included. Click here for more information on rates and product details.
- Mortgage Center
- Beds: 4
- Baths: 4 Full, 2 Half
- Single Family Home
- 5,216 sq ft
SPECTACULAR MEDITERRANEAN STYLE HOME IN GATED WEST SPRINGDALE COMMUNITY, UNIQUE , SPACIOUS HOME THAT FEATURES A SOARING TWO STORY ENTRY WAY WITH IRON ENTRY DOORS, SPECTACTULAR WOOD FLOORS WITH MATCHING STAINED TRIM AND CROWN MOLDING,GOURMET KITCHEN WITH,GRANITE COUNTERS, JEN-AIR APPLIANCES. BUILT IN FRIG,2 LIVING AREAS,4 BED/+OFFICE, THEATER ROOM, PRIVATE BALCONIES, POOL, HOT TUB,3 CAR + GOLF CART GARAGE. THE LIST IS TOO LONG,MUST SEE TO APPRECIATE THE ABSOLUTE BEAUTY OF THIS HOME, 1 YEAR 2-10 HOME WARRANTY Click here to learn more about this listing.
- Single Family Home
- Beds: 4
- Baths: 4 Full, 2 Half
Listing Details
- Attic
- Yes
- Appliances
- Dishwasher, Disposal, Icemaker, Range Hood
- Flooring
- Carpeted, Ceramic, Wood
- Lot Size
- Approximately 16552 Square Feet
- Pool
- Hot Tub/Spa/Jacuzzi
- Roof
- Shingle Roof
- Features
- Stucco Exterior
- Cooling
- Ceiling Fan
- Heating
- Gas
- Assessed Taxable Amount
- $105,740
- Tax Amount
- $4,996
- Last Transaction Date
- 04/06/2009
- Last Transaction Purchase Price
- $487,000
- Property Type
- Single Family Residence
- Bathrooms
- 5
- Floors
- 2
- Home Size (Sqft)
- 4,752
- Year Built
- 2007
- Pool
- Gunite
- Fireplace
- Single
- Parking
- Garage
- Heating System
- Central
- Cooling System
- Central Air
- Exterior Type
- Stucco
Public Facts: As provided by County Assessor and Recorder offices. May not reflect recent additions or improvements. If you see any errors, the best way to get the records updated is to contact your local county records office. If any of the information in this section conflicts with property information provided by a listing agent or broker, agent-provided information should be deemed more reliable.
Local Info
| Median Household Income
| Median Years In Residence
| Median Homeowner Age
| Households with Children
| Percent of Homes Rented
Nearby Elementary Schools
- Oak Grove Montessori School
- 5247 Har Ber Ave
- Bernice Young Elementary School
- 301 Pippin Apple Cir
- Thurman G. Smith Elementary School
- 3600 Falcon Rd
Nearby Middle Schools
- Hellstern Middle School
- 7771 Har Ber Ave
- Central Junior High School
- 2811 W Huntsville Ave
- Helen Tyson Middle School
- 3304 S 40th St
Nearby High Schools
- Har-Ber High School
- 300 Jones Rd
- Shiloh Christian School
- 1707 Johnson Rd
- Springdale High School
- 1103 W Emma Ave
These are the closest schools to your requested location. Proximity does not guarantee enrollment eligibility. Please consult your real estate agent or school district to confirm the schools you are zoned to attend.
Mortgage Rates
Data provided by Informa Research Services. Payments do not include amounts for taxes and insurance premiums. The actual payment obligation will be greater if taxes and insurance are included. Click here for more information on rates and product details.
Property Contact Info
Need More Information?
Please fill out this form to request more photos or more information regarding this property.


text:
5 Min Read
DAKAR (Reuters) - Senegal President Abdoulaye Wade backed down on a proposed change to the election rules on Thursday, completely withdrawing a bill that sparked violent clashes between riot police and protesters in the capital.
Wade's rivals said the proposed change would have guaranteed his re-election against a fragmented opposition in a February poll and had threatened a popular uprising over it in a country long seen as an island of stability in West Africa.
By nightfall the violence had mostly eased but the center of the city was scattered with rocks and the smoldering carcasses of burned out cars. A police source said at least 12 policemen were amongst the more than 100 injured during the violence.
Analysts said the reversal also showed how effectively the opposition and civil society groups could mobilize anti-Wade sentiment amid simmering social tensions in the country.
"The president received messages from far afield, especially our religious leaders, and, as a result, he called on me to withdraw the law," Justice Minister Cheikh Tidiane Sy told the National Assembly.
Wade had earlier withdrawn a proposal to reduce from 50 to 25 percent the minimum score that a candidate would need to win next year's election in the first round -- a level Wade's rivals said would have virtually assured him a first-round win against his fractured opposition.
But other clauses remained and, despite the concession, protesters and members of the security forces, using tear gas and water cannons, continued to clash in areas around the presidency and parliament.
The most controversial remaining clause was the establishment of the position of vice resident.
His rivals say the role was being proposed so he could pass on power to his son Karim, already a "super minister" in charge of a quarter of the nation's budget, but the government said the position would not necessarily be filled by Karim.
Bids on Senegal's eurobond rose by 0.035 cents to 103.554 cents on the dollar, reversing earlier losses.
"We are not at the stage where the market is ready to sell off just because of what's happening, but probably some foreign investors are a little bit nervous about the political outlook ahead of the elections," said Samir Gadio, an emerging markets strategist at Standard Bank.
Ibrahima Sene, a senior member of the opposition Benno Siggil Senegal coalition, praised the protesters for their determination but said their work was only half complete.
"There is still Wade's departure, which we are calling for."
Senegal has long cherished its reputation as West Africa's most stable and democratic country and has had numerous peaceful elections over the past 50 years since independence from France.
But there are increasing concerns over the concentration of power around Wade, and growing frustrations over worsening public services and higher prices for staples.
A campaign called "Don't touch my constitution!" has been launched alongside a group of rappers aimed at increasing youth involvement in the election.
"I think the government didn't expect such a strong reaction from the opposition and civil society," political analyst Djiby Diakhate said. "Behind this there is the problem of the daily problems in Senegal. We are talking about power cuts, floods, corruption and high cost of living."
"This law was just a spark that exposed the daily problems."
Shops were shuttered as Senegalese riot police earlier fired rubber bullets, tear gas and water cannon in clashes with stone-throwing anti-government demonstrators.
Thousands gathered outside the National Assembly building, where lawmakers were due to vote on the bill. There were also reports of clashes elsewhere in Dakar and other cities.
"Listen to us, we are the voice of the people!" one protester shouted at a line of policemen in riot gear. Others, some wearing bandanas to protect themselves from the teargas, shouted "Liberate Senegal!"
The EU and the U.S., top Senegalese donors, have expressed concern over the efforts to swiftly change the constitution.
Additional reporting by Bate Felix and David Lewis in Dakar and Carolyn Cohn in London; Writing by David Lewis and Richard Valdmanis; Editing by Matthew Jones


text:
Catalog Item
$ 2,145.00 $ 1,598.00
Discount from MSRP
Item No. 1406312
Your current wishlist is not saved. Please Log in to save it.
For further information or assistance on this item, call 203-847-1596 ext. 2206.
29.5 x 29 H x 78.5
Custom Options
Also Available In Additional Fabrics And Finishes.


text:
Chicken Korma and Plain Butter Naan at Tandoori Times 2 in Glendale
Nina Tinsley
Where: Tandoori Times 2
5626 West Bell Road, Glendale
When: 11:30 a.m. to 2:30 p.m. (lunch) and 5 to 10 p.m. (dinner) Tuesday through Sunday
Dish and Price: Chicken Korma ($13.95) and Plain Butter Naan ($2.50)
The Setting: Tandoori Times 2 is a brightly decorated eatery; even the industrial-looking air vents are painted a vibrant teal. Indian tapestries hang on the walls and small Indian parasols hang upside down from the ceiling. The pops of color make the simple, undivided space feel comfortable and warm.
The Dish: The large portion of chicken korma was both creamy and acidic. A strong curry flavor took center stage, and the korma had the slightest hint of tomato. We were surprised that the dish didn't have much excess sauce to be mopped up with our side of plain butter naan, though the starch also tasted just fine on its own (more on that later). The large but still bite-size chunks of dark meat were super-tender and the richness of the chicken made a great complement to the curry. If we had a day to wastein our sweatpants on the couch, we'd have endless bowls of this ultimate comfort dish delivered to us.
Tandoori Times 2's plain butter naan was among the best we've had in the Valley. Each bite offered something different, with some thick, doughy pieces and some thin, crispy, almost-burnt bites. The blackened parts had an addicting charred marshmallow quality about them.
The Best Part: Surprisingly, one of the best parts about this dish was the chutneys accompanying it. Our favorite was the lemon, jalapeño, and ginger pickle. When we added this punchy side, complete with whole chunks of lemon (rind and all) and whole ginger pieces, to the creamy Korma, the new flavor combination was out of this world.
The One Thing We'd Change: The naan is so good, we wish more came in an order. Though $2.50 feels pricy for one piece of bread, you really can't (or at least don't want to) have just one.
The interior of Tandoori Times 2 is bright and colorful.
Nina Tinsley
Get the Food & Drink Newsletter
Our weekly guide to Phoenix dining includes food news and reviews, as well as dining events and interviews with chefs and restaurant owners.
From Our Sponsors
Popular Stories
Sponsor Content


text:
Welcome guest, Sign in
Doc. rer. nat., FSU, Jena, DE, 2007
Current position
Junior professor of Molecular Ecology, Institute of Biology, Freie Universität Berlin, DE (01/2009-present)
Publications (since 2004)
About Us |
What's New |
Author Map |
Terms of Service |
Copyright & IP Policy |
Contact Us
© 2017 Bio-protocol LLC. ISSN: 2331-8325


text:
From WikiLou
This is a category for everything to do with baseball in St. Louis.
If you want to add a page to this list you can simply add the text
]] to its content.
This category has the following 5 subcategories, out of 5 total.
Pages in category "Baseball"
The following 17 pages are in this category, out of 17 total.


text:
Each month, Rated People connects over 50,000 homeowners with quality tradesmen - simply enter your job details in the form above to get started.
We'll match your job to the relevant tradesmen in your area - those interested will pay to see your contact details and call you to quote.
As each tradesman expresses interest in quoting on your job, we'll send you their profile and ratings to help you choose the right one for you.
After the work is complete, return to the site and rate your tradesman based on their quality of work, reliability and value for money.
Gardener / Landscape gardeners
Added 03/06/2017
Services required: lawn mowing and edging, weeding, pruning, hedge trimming Approximate length...
Searching for tradespeople
Gardener / Garden Designer
Added 22/03/2017
Services required: create borders, lawn seeding, planting, Weeding, pruning apple trees and...
Added 29/06/2016
SMall sloping roof at front of house has a small area of danged tiles which need replacing....
Searching for tradespeople
Heating Engineer
Added 06/05/2016
Service gas appliance and issue safety certificate 1 x boiler, 1 x cooker, 1 x gas fire Make...
Searching for tradespeople
Bathroom Specialist
Added 29/04/2016
Install 1 x basin, 1 x electric shower, 1 x extractor fan, 1 x heated towel rail, 1 x shower...
Searching for tradespeople
Painter / Decorator
Added 20/04/2016
Painting of 21+ external wooden windows and 5 sets of patio doors. Also paining of eternal...
Searching for tradespeople
Managing your job is easier with the Rated People Homes App, download it today.


text:
We are pleased that you are interested in applying to Sc. Farzand Husain Islamic International Academy. In brief, the application to SFHIIA includes an admission test, and a parent interview.
Also, personal behavior and academic excellence are important criteria for acceptance at SFHIIA. We first recommend that you and your family pay a brief visit to SFHIIA. This will help you see the school in action and meet a member of our admission staff who will provide a school tour and arrange a staff and family conference where you will be able to ask questions and have a sense of how SFHIIA will help in your child's development and growth.
To get started, please download and complete the form below. Kindly bring the form duly filled to the We look forward to meeting you!
Click here to download the Registration Form.
Kindly bring the form duly filled to the We look forward to meeting you!
SFHIIA Admissions Policy
The intention of the Sc. Farzand Husain Islamic International Academy is to provide the best possible academic education and Islamic education within an Islamic environment. In order to do so, a certain admissions policy is established.
Age: Junior kindergarten children should be 4 years old, senior kindergarten children should be 5 years old, and grade one children should be 6 years old by December 31 of the year of admission.
Academics: General achievement should not be more than three months below grade placement. Exceptions will be made in unusual circumstances if lower achievement can be satisfactorily explained and the program will be helpful.
Behaviour: Students from other schools must have a Transfer Certificate record or recommendation that is average or above average in order to be granted admission. Applicants must agree to honour the school's behavioural code. This includes behaving in a manner that reflects Islamic principles and that is consistent with a conservative, Islamic way of life. Students are expected to respect their teachers, peers, and the environment.
Attitude: Children at pre-school level, should have a general eagerness toward learning in accordance with their age. Children who have developed contempt for the Islamic way of life will not be enrolled. Children above the grade 4 level should be attending the school by their own choice.
Students in elementary grades and above should also demonstrate a positive attitude toward their education, a willingness to work hard toward achieving the goals of education, and a sincere desire to continue their education at SFHIIA. They must also accept and maintain a positive attitude toward the Islamic nature of the school environment and standards.
Uniform: Applicants must agree to wear the school uniform in accordance with the uniform guidelines and must accept the school's right to set limits in other areas of personal appearance.
It should be understood that families who may satisfy the above general standards may still not gain admission to the school the first year that they apply, simply due to a lack of available space.
Family Discounts: Tuition fees are set annually and structured to provide for the operating needs of the school. As a family-oriented school, the rates are kept as reasonable as possible to make the program affordable to most families. For that reason, there are generous discounts when more than one child from a family is enrolled.
School Uniform
Uniform for boys is available at the school which includes;
- shirt
- pant
- vest
- blazer
Uniform for preschool till grade 5 is distributed at school. Grade 5 and above should wear black abaya and scarf. No added accessories.


text:
JAPAN: Nissan after more emergency loan funds - paper
Nissan Motor wants a further JPY100bn (US$1.01bn) from the emergency government loan fund to help Japanese firms cope with the global economic crisis, a newspaper report said on Wednesday.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-auto gives its paid members access to the very best automotive market coverage.
And now there's just-auto plus, our premium membership that gives you exclusive component forecast data, company profiles and extended news coverage - just for premium members.
Today I can offer you 30 days access for $1 - and that includes just-auto plus.
Dave Leggett, editor of just-auto
* plus VAT if applicable
Only on


text:
Gasp! Comcast just made HBO available without a cable subscription
Finally, fans may be able to watch Game of Thrones and Boardwalk Empire without being forced to pay for the Game Show Network.
A data-rich view of all the (sometimes invisible) third-party sites that are watching your digital footprint.
Now screaming: 13 flicks for your All Hallows horror binge
These online Halloween goodies are so scary that they'll still be rattling around in your head long after the Great Pumpkin has disappeared for another year.
No, YouTube, the world does not want to pay for music videos
YouTube is reportedly considering a pay service to watch music videos. Here's why they shouldn't do that.
Galaxy Gear to finally play nice with Galaxy S4, SIII, Note 2, and other Samsung devices
Will the move help Gear become a viable part of the mobile market. (Hint: probably not.)
Warning: The OS X Mavericks phishing scams have already begun
Mac users beware!
HTC enters smartwatch fray; my wrist remains unimpressed
There is nothing exciting about smartwatches. So, why all the hubbub?
Microsoft reportedly sourcing components for its own smart eyeglasses
Microsoft is attempting to find its footing in the mobile space by embracing brave new form factors.
The cords are losing: Netflix overtaking HBO in paid U.S. subscribers
The momentum continues to shift away from the traditional cable model, as customers increasingly turn to streaming services like Netflix.
A flurry of leaks all but confirms supersized Lumia 1520 Windows Phone coming soon
We'll surely have all the deets this time tomorrow.
Bye bye battery? Volvo demos rechargeable batteries embedded in a car's body
Traditional electric-car batteries that are bulky may soon be a thing of the past.
Don't spend $150 to bring Samsung's clunky smart TV experience to your set
Samsung's new $150 set-top device will turn any dumb TV smart, but there's a lot of better options out there.
BitTorrent teams up with Vice to distribute original video content for hipsters
BitTorrent is shedding its bad reputation and working hard to become a content distribution platform.
Samsung's curved Galaxy Round phone reportedly won't be available to the rest of the world anytime soon
According to reports, the curved Round is a limited run only for the Korean market.
Chill out, Julian, you come out looking pretty good in 'The Fifth Estate'
Despite Julian Assange's charges to the contrary, the new movie paints WikiLeaks (and its founder) in a flattering light.
Articles by Evan DashevskyNext Page


text:
Call Us Toll Free
Email Us
Customer Services
Call Us Toll Free
Email Us
Customer Services
50% off
Was $38.00 Now $19.00
Luxuriously hand-finished with intarsia detail - little trains emerging from the side of the top - our tank is the perfect complement to one of our long-sleeved tops or rompers. With contrasting colors on the trims and seams, it features a striped central panel and a buttoned placket on the shoulder, ensuring it's easy to get baby in and out of.
100% cotton
Available in ecru marl
Machine wash warm
STANDARD NON-TRACKABLE SHIPPING - $9.95 (unless a promotion has been applied) Please allow 6-10 business days for delivery. May require a signature.
STANDARD TRACKABLE SHIPPING - $13.95 (unless a promotion has been applied) Please allow 5-9 business days for delivery. May require a signature.
EXPRESS SHIPPING - $35.95 Please allow up to 4 business days for delivery. Order by 12pm EST Monday to receive by Friday. May require a signature.
SHIPPING OUTSIDE THE US - Please allow 14 business days for delivery. Click here for International shipping charges
Please select your preferred shipping option at checkout
The White Company pays all import taxes and duties on your behalf.
More shipping information including charges
Returns – FREE (for the US) – Smart label returns are convenient and easy.
Click here for more returns information, including smart returns labels
Just tick the gift-box option during checkout to make it even more special.
FREE standard delivery on orders over £50 (usually £4.95). For next day delivery, order before midday (£7.95).
Our delivery rates to Europe start from £7 and usually take 5 - 7 working days. If ordering from the US (rates from £15) or Australia (rates from £20), please allow 10 - 14 days for delivery.